IP Library Granted Patent US 11,111,265
Granted Patent B2
US 11,111,265 · App. 16/759,134 · Granted Sep 7, 2021

Method for preparing cholic acid compound

Inventors: Xiquan Zhang (Lianyungang, CN); Xingdong Cheng (Lianyungang, CN); Aiming Zhang (Lianyungang, CN); Chunguang Xia (Lianyungang, CN); Lang Chen (Lianyungang, CN); Ce Gao (Lianyungang, CN)
Assignee: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
C07J9/005
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,111,265
App. No.
16/759,134
Granted
Sep 7, 2021
Kind
B2
Abstract

The present application relates to a method for preparing a cholic acid compound. Specifically, the method prepares a compound as shown in formula I, including subjecting a compound of formula 2 to an oxidization reaction to obtain a compound of formula 3; attaching a trimethylsilyl group to the compound of formula 3 to obtain a compound of formula 4; reacting the compound of formula 4 with acetaldehyde to obtain a compound of formula 5; subjecting the compound of formula 5 to a catalytic hydrogenation reaction to obtain a compound of formula 6; and converting a cyano group of the compound of formula 6 to a carboxyl group to give the compound of formula I.

Claims (29)

1. A preparation method for a compound of formula I,

comprising the following steps:

a) subjecting a compound of formula 2 to an oxidization reaction in a solvent to obtain a compound of formula 3,

b) attaching a protecting group to the compound of formula 3 in a solvent to obtain a compound of formula 4,

c) reacting the compound of formula 4 with acetaldehyde in a solvent to obtain a compound of formula 5,

d) subjecting the compound of formula 5 to a reduction reaction in a solvent under a catalyst to obtain a compound of formula 6,

e) converting cyano group of the compound of formula 6 to a carboxyl group to give the compound of formula I,

wherein, said R 1 and R 2 are each independently selected from a silyl ether protecting group.

2. The preparation method of claim 1 , wherein the preparation method for the compound of formula 2 comprises the following steps:

f) attaching a formyl group to a compound of formula 7 to obtain a compound of formula 8,

g) converting a carboxyl group at position 23 of the compound of formula 8 to a cyano group at position 22 to obtain a compound of formula 9, and removing a formyl group from the compound of formula, 9 to obtain the compound of formula 2,

3. The preparation method of claim 1 , wherein the silyl ether protecting group is selected from trimethylsilyl, triethylsilyl, tert-butyldimethylsilyl, or tert-butyldiphenylsilyl.

4. The preparation method of claim 1 , wherein an oxidant used in said step a) is selected from sodium hypochlorite, bromine hypochlorite, N-bromosuccinimide, N-chlorosuccinimide, hydrogen peroxide or potassium dichromate.

5. The preparation method of claim 4 , wherein in said step a, the molar ratio of the compound of formula 2 to the oxidant is selected from 1:(1 to 5).

6. The preparation method of claim 1 , wherein said step a) is performed in the presence of bromine.

7. The preparation method of claim 1 , wherein the solvent of said step a) is selected from dichloromethane, methanol, ethanol, propanol, diethyl ether, isopropyl ether, tetrahydrofuran, methyl tert-butyl ether, ethyl acetate, acetonitrile, acetone, or a mixed solvent thereof.

8. The preparation method of claim 1 , wherein said step a) is performed in the presence of an organic acid, which is selected from formic acid, acetic acid, propionic acid, citric acid or malic acid.

9. The preparation method of claim 1 , wherein said step b) is performed in the presence of an alkali metal cationic organic base, which is selected from lithium diisopropylamide, n-butyllithium, sodium diisopropylamide, potassium diisopropylamide, sodium hexamethyldisilazide, potassium hexamethyldisilazide or lithium hexamethyldisilazide.

10. The preparation method of claim 1 , wherein said step b) is performed in the presence of an acid-binding agent, which is selected from triethylamine, diisopropylethylamine, tributylamine or pyridine.

11. The preparation method of claim 1 , wherein said step c) is performed in the presence of boron trifluoride; aluminum trichloride, iron trichloride, zinc chloride, tin tetrachloride or niobium pentachloride.

12. The preparation method of claim 1 , wherein the catalyst of said step d) is selected from Pd/C, PVC, Pt/C, Rh(OH) 2 , Raney Ni, or PtO 2 .

13. The preparation method of claim 1 , wherein said step e) is performed in the presence of NaOH or KOH.

14. The preparation method of claim 2 , Wherein said step f is performed in formic acid.

15. The preparation method of claim 2 , wherein in said step g), the compound of formula 8 is converted to the compound of formula 9 in the presence of trifluoroacetic acid or trifluoroacetic anhydride, and sodium nitrite or potassium nitrite.

16. The preparation method of claim 1 , wherein said step a) is performed in the presence of sodium bromide or potassium bromide.

17. The preparation method of claim 1 wherein the solvent of said step b) is selected from n-heptane, n-hexane, tetrahydrofuran, methyl tert-butyl ether or toluene.

18. The preparation method of claim 1 , wherein the solvent of said step c) is selected from n-heptane, n-hexane, tetrahydrofuran; methyl tert-butyl ether, toluene or dichloromethane.

19. The preparation method of claim 1 , wherein the solvent of said step d) is selected from methanol, ethanol, propanol or tetrahydrofuran.

20. The preparation method of claim 2 , wherein in step g), a reaction of removing the formyl group from the compound of formula 9 is performed in an aqueous solution of NaOH or KOH.

Assignments (2)
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNEE NAME ERRONEOUSLY SUBMITTED AS: CHIA TAI TIANQING PHARMACEUTAL GROUP CO., LTD. PREVIOUSLY RECORDED ON REEL 052490 FRAME 0788. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Aug 12, 2020
From: ZHANG, XIQUAN; CHENG, XINGDONG; ZHANG, AIMING; XIA, CHUNGUANG; CHEN, LANG; GAO, CE
To: CHIA TAI TIANQING PHARMACEUTICAL GROUP CO., LTD.
Reel/Frame 053470/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2020
From: ZHANG, XIQUAN; CHENG, XINGDONG; ZHANG, AIMING; XIA, CHUNGUANG; CHEN, LANG; GAO, CE
To: CHIA TAI TIANQING PHARMACEUTAL GROUP CO., LTD.
Reel/Frame 052490/0788 →
Priority Claims (1)
CN 201711062367.6 · Nov 2, 2017 · national
Continuity (1)
Related Publication 20200347091A1 · Nov 5, 2020